Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Journal of Virology
|
December 1, 1993
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2
S P Lee, W A Thomas, R J Murray, et al.
European Journal of Immunology
|
January 1, 1995
Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population
S P Lee, S Morgan, J Skinner, et al.
FEBS Letters
|
January 9, 1984
New potent inhibitors of angiotensin converting enzyme
M R Attwood, R J Francis, C H Hassall, et al.
European Journal of Gastroenterology & Hepatology
|
January 28, 2023
Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study
Pepijn W A Thomas, Mark van Caem, Rachel L West, et al.
Gastro Hep Advances
|
August 12, 2024
Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective
Damien S E Broekharst, Pepijn W A Thomas, Maurice G V M Russel, et al.
Pharmacoepidemiology and Drug Safety
|
November 21, 2020
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system
Pepijn W A Thomas, Rachel L West, Maurice G V M Russel, et al.
Digestive Diseases and Sciences
|
May 2, 2023
Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
Fenna M Jansen, Lisa J T Smits, Pepijn W A Thomas, et al.
Experimental and Molecular Pathology
|
October 1, 1993
Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction
D N Kim, J Schmee, J E Baker, et al.
United European Gastroenterology Journal
|
June 2, 2021
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy
Pepijn W A Thomas, Tessa E H Römkens, Rachel L West, et al.
Inflammatory Bowel Diseases
|
February 8, 2022
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study
Pepijn W A Thomas, Nathan den Broeder, Monique Derikx, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Journal of Virology
|
December 1, 1993
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2
S P Lee, W A Thomas, R J Murray, et al.
European Journal of Immunology
|
January 1, 1995
Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population
S P Lee, S Morgan, J Skinner, et al.
FEBS Letters
|
January 9, 1984
New potent inhibitors of angiotensin converting enzyme
M R Attwood, R J Francis, C H Hassall, et al.
European Journal of Gastroenterology & Hepatology
|
January 28, 2023
Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study
Pepijn W A Thomas, Mark van Caem, Rachel L West, et al.
Gastro Hep Advances
|
August 12, 2024
Health State Questionnaires Deployed in Ulcerative Colitis Patients: The Medical, Psychological, and Economic Perspective
Damien S E Broekharst, Pepijn W A Thomas, Maurice G V M Russel, et al.
Pharmacoepidemiology and Drug Safety
|
November 21, 2020
Inflammatory bowel disease patients provide reliable self-reported medical information: A multicentre prospective pharmacovigilance monitoring system
Pepijn W A Thomas, Rachel L West, Maurice G V M Russel, et al.
Digestive Diseases and Sciences
|
May 2, 2023
Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy
Fenna M Jansen, Lisa J T Smits, Pepijn W A Thomas, et al.
Experimental and Molecular Pathology
|
October 1, 1993
Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction
D N Kim, J Schmee, J E Baker, et al.
United European Gastroenterology Journal
|
June 2, 2021
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy
Pepijn W A Thomas, Tessa E H Römkens, Rachel L West, et al.
Inflammatory Bowel Diseases
|
February 8, 2022
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study
Pepijn W A Thomas, Nathan den Broeder, Monique Derikx, et al.
Page
of 14